Olivier Gaide

7.5k total citations · 3 hit papers
79 papers, 5.7k citations indexed

About

Olivier Gaide is a scholar working on Molecular Biology, Oncology and Dermatology. According to data from OpenAlex, Olivier Gaide has authored 79 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 26 papers in Oncology and 24 papers in Dermatology. Recurrent topics in Olivier Gaide's work include Nonmelanoma Skin Cancer Studies (18 papers), NF-κB Signaling Pathways (12 papers) and Cutaneous Melanoma Detection and Management (11 papers). Olivier Gaide is often cited by papers focused on Nonmelanoma Skin Cancer Studies (18 papers), NF-κB Signaling Pathways (12 papers) and Cutaneous Melanoma Detection and Management (11 papers). Olivier Gaide collaborates with scholars based in Switzerland, United States and France. Olivier Gaide's co-authors include Jürg Tschopp, Pascal Schneider, Olivier Micheau, Fabio Martinon, Susanne M.A. Lens, Jürg Tschopp, Aubry Tardivel, Lars E. French, Margot Thome and Sylvie Hertig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Olivier Gaide

70 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NF-κB Signals Induce the Expression of c-FLIP

2001 692 citations Olivier Micheau, Olivier Gaide et al. profile →
Treatment of a first patient with FLASH-radiotherapy

2019 597 citations Jean Bourhis, Wendy Jeanneret Sozzi et al. Radiotherapy and Oncology profile →
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity

2015 447 citations Olivier Gaide, Fabio Martinon et al. profile →

Peers

Countries citing papers authored by Olivier Gaide

Since Specialization

Citations

This map shows the geographic impact of Olivier Gaide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Gaide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Gaide more than expected).

Fields of papers citing papers by Olivier Gaide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Gaide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Gaide. The network helps show where Olivier Gaide may publish in the future.

Co-authorship network of co-authors of Olivier Gaide

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Gaide. A scholar is included among the top collaborators of Olivier Gaide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Gaide. Olivier Gaide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase 1 dose escalation trial of FLASH radiotherapy in patients with skin metastases from melanoma 2025 ·Rémy Kinj, Sushil Allen Luis, Martine Raphaël, Jean Bourhis, Olivier Gaide	1
2	High-Frequency Basal Cell Carcinoma: Demographic, Clinical, and Histopathological Features in a Belgian Cohort 2025 ·Journal of Clinical Medicine ·Klaus Wunderlich, Carmen Orte Cano, Mariano Suppa, Olivier Gaide, Jonathan M. L. White, Hassane Njimi, (unknown), (unknown)	0
3	Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol 2024 ·Clinical and Translational Radiation Oncology ·Rémy Kinj, Olivier Gaide, Wendy Jeanneret‐Sozzi, Urania Dafni, (unknown), (unknown), Magdalini Kypriotou, (unknown), F. Duclos, (unknown), Teresa Falco, (unknown), Patrik Gonçalves Jorge, Raphaël Moeckli, Jean Bourhis	19
4	Positive Impact of UV Photography on Individual Sun Protection: A Swiss Feasibility Study 2024 ·International Journal of Public Health ·Tanguy Corre, (unknown), Olivier Gaide, David Vernez, Jean‐Luc Bulliard	0
5	Mpox (variole du singe) : l’œil du dermatologue 2023 ·Revue Médicale Suisse ·(unknown), (unknown), Damien Pastor, Laurence Toutous Trellu, (unknown), Olivier Gaide	1
6	Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation 2022 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Bettina Bisig, Anne Cairoli, Olivier Gaide, Joan Somja, (unknown), Philippe Gaulard, Luc Xerri, Karine Lefort, Edoardo Missiaglia, Michel Gilliet, Daniel Hohl, Emmanuella Guenova, Laurence de Leval	2
7	Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma 2022 ·Radiotherapy and Oncology ·Olivier Gaide, Fernanda Herrera, Wendy Jeanneret Sozzi, Patrik Gonçalves Jorge, Rémy Kinj, Claude Bailat, F. Duclos, François Bochud, Jean‐François Germond, (unknown), (unknown), Luis Schiappacasse, Mahmut Özsahin, Raphaël Moeckli, Jean Bourhis	59
8	Treatment of a first patient with FLASH-radiotherapy breakdown → 2019 ·Radiotherapy and Oncology ·Jean Bourhis, Wendy Jeanneret Sozzi, Patrik Gonçalves Jorge, Olivier Gaide, Claude Bailat, F. Duclos, David Patin, Mahmut Özşahin, François Bochud, Jean‐François Germond, Raphaël Moeckli, Marie‐Catherine Vozenin	597
9	Ingenol Mebutate 500 μg for Treatment of the Scalp in Refractory Field Cancerization 2016 ·Dermatology ·Olivier Gaide, (unknown), (unknown), François Kuonen	2
10	Common clonal origin of central and resident memory T cells following skin immunization 2015 ·Nature Medicine ·Olivier Gaide, Ryan Emerson, Xiaodong Jiang, Nicholas Gulati, (unknown), Cindy Desmarais, Harlan Robins, James G. Krueger, Rachael A. Clark, Thomas S. Kupper	217
11	Nouvelle lumière sur la thérapie photodynamique cutanée 2014 ·Revue Médicale Suisse ·François Kuonen, Olivier Gaide	1
12	Swiss clinical practice guidelines on field cancerization of the skin 2014 ·Swiss Medical Weekly ·Günther F.L. Hofbauer, M.D. Anliker, Wolf‐Henning Boehncke, C.U. Brand, Ralph P. Braun, Olivier Gaide, Jürg Hafner, (unknown), Peter Itin, (unknown), Stephan Lautenschlager, Carlo Mainetti, Markus Streit	40
13	Carcinome de Merkel : (r)évolution 2013 ·Revue Médicale Suisse ·Laurence Feldmeyer, Olivier Gaide	0
14	Molecular and Therapeutic Characterization of Anti-ectodysplasin A Receptor (EDAR) Agonist Monoclonal Antibodies 2011 ·Journal of Biological Chemistry ·(unknown), N. Dunkel, Laure Willen, Margret L. Casal, Elizabeth A. Mauldin, Olivier Gaide, Aubry Tardivel, (unknown), (unknown), (unknown), Douglas M. Jefferson, Denis J. Headon, Stéphane Demotz, Pascal Schneider	32
15	Gene therapy and protein therapy of ectodermal dysplasias: A perspective 2009 ·American Journal of Medical Genetics Part A ·Olivier Gaide	0
16	Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X‐linked ectodermal dysplasia 2009 ·American Journal of Medical Genetics Part A ·Elizabeth A. Mauldin, Olivier Gaide, Pascal Schneider, Margret L. Casal	36
17	Danger Signaling through the Inflammasome Acts as a Master Switch between Tolerance and Sensitization 2008 ·The Journal of Immunology ·Hideki Watanabe, Samuel Gehrke, Emmanuel Contassot, (unknown), Jürg Tschopp, Peter S. Friedmann, Lars E. French, Olivier Gaide	73
18	Insight into the inflammasome and caspase-activating mechanisms 2007 ·Expert Review of Clinical Immunology ·Olivier Gaide, Hal M. Hoffman	6
19	Interactions of Tumor Necrosis Factor (TNF) and TNF Receptor Family Members in the Mouse and Human 2006 ·Journal of Biological Chemistry ·Claudia Bossen, (unknown), Aubry Tardivel, Jean-Luc Bodmer, Olivier Gaide, Sylvie Hertig, Christine Ambrose, Jürg Tschopp, Pascal Schneider	346
20	Carma1, a CARD‐containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF‐κB activation¹ 2001 ·FEBS Letters ·Olivier Gaide, Fabio Martinon, Olivier Micheau, David J. Bonnet, Margot Thome, Jürg Tschopp	170

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact